CollPlant Biotechnologies (CLGN) Receivables - Net (2017 - 2026)

CollPlant Biotechnologies has reported Receivables - Net for 10 years, with the latest figure at $8000.0 in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net changed N/A year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $8000.0 (changed N/A YoY), and the FY2025 full-year result was $1000.0, down 100.0% from the prior year.
• Receivables - Net for Q1 2026 stood at $8000.0, up from $1000.0 in the prior quarter.
• The five-year high for Receivables - Net was $150.0 million in Q4 2024, with the low at $1000.0 in Q4 2025.
• Historically, Receivables - Net has averaged $22.4 million across 5 years, with a median of $2.2 million in 2023.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 112788.89% — and 2025, when it sank 100.0%.
• CollPlant Biotechnologies' Receivables - Net stood at $9.0 million in 2022, then slumped by 55.56% to $4.0 million in 2023, then soared by 3650.0% to $150.0 million in 2024, then slumped by 100.0% to $1000.0 in 2025, then jumped by 700.0% to $8000.0 in 2026.
• The last three Receivables - Net figures came in at $8000.0 (Q1 2026), $1000.0 (Q4 2025), and $150.0 million (Q4 2024), per Business Quant data.